UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. )*

Ucellit.com, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

90348 M 103

(CUSIP Number)

Michael Kirsh
1815 Creelman Avenue
Vancouver, British Columbia, Canada V6J 1B7
(604) 269-9881

(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)

March 20, 2000

(Date of Event which Requires Filling of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1 (f) or 240.13d-1(g), check the following box. ( )

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D
CUSIP No. 90348 M 103

	1.	Names of Reporting Persons. Michael Kirsh I.R.S. Identification No.

	2.	Check the Appropriate Box if a Member of a Group* (a.) ( ) (b.) ( )

	3.	SEC USE ONLY

	4.	Source of Funds* OO

5. Check if Disclosure of Legal Proceedings Is Required Pursuant to items 2(d) or 2(e) ( )

6. Citizenship or Place of Organization
Canada

Number of
Shares
Beneficially
Owned by
Each Reporting
Person With 7. Sole Voting Power
1,500,000 shares

8. Shared Voting Power

9. Sole Dispositive Power
1.500,000 shares

10. Shared Dispositive Power

11. Aggregate Amount Beneficially Owned by Each Reporting Person
1,500,000 shares

12. Check if the Aggregate Amount Represented by Amount in Row (11) Excludes Certain Shares
(See Instructions) ( )

13. Percent of Class Represented by Amount in Row (11)
67%

14. Type of Reporting Person
IN

Item 1. Security and Issuer Common Stock UCELLIT.COM INC. 2445 West 16 Vancouver, British, Canada V6K 3B9

Item 2. Identity and Background.

(a)	Name: Dr. Michael Kirsh

(b)	Residence or business address: 1815 Creelman Avenue Vancouver, British Columbia, Canada, V6J 1B7

(c)	Present Principal Occupation or Employment: Dentist, investor and President of Gold Pick Mines, Inc.

(d)	Criminal Conviction: No.

(e)	Court or Administrative Proceedings: No.

(f)	Citizenship: Canada

Item 3. Source and Amount of Funds or Other Consideration: On March 20, 2000, Ucellit.com, Inc. issued to Dr. Michael Kirsh 1,500,000 shares of Ucellit.com, Inc.'s common stock and a promissory note for $28,000 in exhange for Dr. Kirsh's rights under a license agreement with Vitamineralherb.com.

Item 4. Purpose of Transaction State the purpose or purposes of the acquisition of securities of the issuer. Describe any plans or proposals which the reporting persons may have which relate to or would result in:
Dr. Kirsh was the founding shareholder shareholder of Ucellit.com, Inc.
3
(a)	The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer;
None.
(b)	An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries;
None.
(c)	A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries;
None.
(d)	Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;
None.
(e)	Any material change in the present capitalization or dividend policy of the issuer;
None.
(f)	Any other material change in the issuer's business or corporate structure including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940;
None.
(g)	Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person;
None.
(h)	Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;
None.
(i)	A class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or
None.
(j)	Any action similar to any of those enumerated above.
None.


Item 5. Interest in Securities of the Issuer.

(a)	1,500,000 shares of common stock, which is approximately 67% of the outstanding common stock.

(b)	Sole voting: 1,500,000 shares of common stock. Sole power to dispose: 1,500,000 shares of common stock.

(c)	None.


(d)	None.

(e)	Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. None.
4

Item 7. Material to be Filed as Exhibits. None.

Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: June 23, 2003
	By:	/s/ Dr. Michael Kirsh, D.D.S. Dr. Michael Kirsh, D.D.S.
	Title:		Individual


5

KIRSH MICHAEL SC 13D